Myelomodulatory treatments augment the therapeutic benefit of oncolytic viroimmunotherapy in murine models of malignant peripheral nerve sheath tumors.

Front Immunol · 2024 · PMC11263800 · PMID 39044819

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

T-VEC consistently exhibited an increasing trend in virus yield over the 72 hours, while both HSV1716 and C134 demonstrated a decline in virus production in both cell lines.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.